Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details)

v3.5.0.2
Summary of Significant Accounting Policies (Details)
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jan. 01, 2016
Dec. 31, 2015
USD ($)
Sep. 30, 2016
USD ($)
Sep. 30, 2015
USD ($)
Jun. 30, 2016
USD ($)
Sep. 30, 2016
USD ($)
Segment
Sep. 30, 2015
USD ($)
Dec. 31, 2015
USD ($)
Summary of Significant Accounting Policies [Line Items]                
Provision for inventory obsolescence           $ 200,000 $ 700,000  
Pre-launch inventory   $ 0 $ 0     0   $ 0
Goodwill, in-process research and development and other intangible assets acquired   2,200,000,000 2,100,000,000     2,100,000,000   2,200,000,000
Amortization expense     18,116,000 $ 8,110,000   47,337,000 14,011,000  
In-process research and development   792,275,000 646,970,000     646,970,000   792,275,000
Intangible assets, net   638,152,000 781,890,000     781,890,000   638,152,000
Depreciation expense           25,300,000 6,100,000  
Release of valuation allowance       93,400,000     93,400,000  
Revenue from transfer of intellectual property and other     18,441,000 18,350,000   105,338,000 48,552,000  
Total deferred revenue   232,900,000 180,400,000     180,400,000   232,900,000
Accounts receivable, gross   219,043,000 264,957,000     264,957,000   219,043,000
Allowance for doubtful accounts receivable   25,168,000 41,130,000     41,130,000   25,168,000
Provision for bad debts           62,500,000 8,300,000  
Equity-based compensation expense           $ 34,939,000 $ 17,765,000  
Number of reportable segments | Segment           2    
Minimum                
Summary of Significant Accounting Policies [Line Items]                
Intangible assets, estimated useful lives           3 years    
Maximum                
Summary of Significant Accounting Policies [Line Items]                
Intangible assets, estimated useful lives           20 years    
Government Contracts Concentration Risk                
Summary of Significant Accounting Policies [Line Items]                
Accounts receivable, gross   $ 26,100,000 31,100,000     $ 31,100,000   $ 26,100,000
Government Contracts Concentration Risk | Sales Revenue, Net                
Summary of Significant Accounting Policies [Line Items]                
Concentration percentage           10.00% 9.00%  
Software                
Summary of Significant Accounting Policies [Line Items]                
Property, plant and equipment, estimated useful lives           3 years    
Machinery, Medical and Other Equipment | Minimum                
Summary of Significant Accounting Policies [Line Items]                
Property, plant and equipment, estimated useful lives           5 years    
Machinery, Medical and Other Equipment | Maximum                
Summary of Significant Accounting Policies [Line Items]                
Property, plant and equipment, estimated useful lives           8 years    
Furniture and Fixtures | Minimum                
Summary of Significant Accounting Policies [Line Items]                
Property, plant and equipment, estimated useful lives           5 years    
Furniture and Fixtures | Maximum                
Summary of Significant Accounting Policies [Line Items]                
Property, plant and equipment, estimated useful lives           10 years    
Buildings and Improvements | Minimum                
Summary of Significant Accounting Policies [Line Items]                
Property, plant and equipment, estimated useful lives           10 years    
Buildings and Improvements | Maximum                
Summary of Significant Accounting Policies [Line Items]                
Property, plant and equipment, estimated useful lives           40 years    
Automobiles and Aircraft | Minimum                
Summary of Significant Accounting Policies [Line Items]                
Property, plant and equipment, estimated useful lives           3 years    
Automobiles and Aircraft | Maximum                
Summary of Significant Accounting Policies [Line Items]                
Property, plant and equipment, estimated useful lives           15 years    
Collaborative Arrangement, Product | Pfizer                
Summary of Significant Accounting Policies [Line Items]                
Revenue from transfer of intellectual property and other     17,700,000 $ 17,700,000   $ 53,000,000 $ 47,800,000  
Total deferred revenue     $ 176,500,000     $ 176,500,000    
Self-Pay | Accounts Receivable                
Summary of Significant Accounting Policies [Line Items]                
Concentration percentage           6.60%   7.50%
Internal Revenue Service (IRS)                
Summary of Significant Accounting Policies [Line Items]                
Corporate income tax rate     35.00%     35.00%    
Israel Tax Authority                
Summary of Significant Accounting Policies [Line Items]                
Corporate income tax rate 25.00% 26.50%       25.00%    
Scenario, Adjustment                
Summary of Significant Accounting Policies [Line Items]                
In-process research and development         $ (187,600,000)      
Intangible assets, net         $ 187,600,000      
In-process Research and Development                
Summary of Significant Accounting Policies [Line Items]                
Intangible assets, estimated useful lives         12 years